HighTower Advisors’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Buy
+10,738
New +$96.1K ﹤0.01% 3629
2025
Q3
Sell
-10,320
Closed -$35.7K 4023
2025
Q2
$35.7K Sell
10,320
-236,856
-96% -$705K ﹤0.01% 3578
2025
Q1
$648K Buy
247,176
+47,433
+24% +$186K ﹤0.01% 2268
2024
Q4
$823K Buy
199,743
+44,823
+29% +$244K ﹤0.01% 2105
2024
Q3
$1.1M Sell
154,920
-148,425
-49% -$1.11M ﹤0.01% 1884
2024
Q2
$1.98M Buy
303,345
+56,054
+23% +$383K ﹤0.01% 1459
2024
Q1
$2.06M Buy
247,291
+34,500
+16% +$337K ﹤0.01% 1422
2023
Q4
$2.34M Sell
212,791
-72,552
-25% -$612K ﹤0.01% 1353
2023
Q3
$2.4M Buy
+285,343
New +$3.07M ﹤0.01% 1281
2022
Q3
Sell
-17,941
Closed -$302K 3358
2022
Q2
$302K Buy
+17,941
New +$385K ﹤0.01% 2359

Other funds holding RLAY